Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 200 of 715 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 04/30/06
Due: 04/30/07
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 09/30/08
Due: 09/30/09
Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 08/31/06
Due: 08/31/07
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 12/31/04
End: 12/31/05
Due: 12/31/06
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 06/30/03
End: 02/28/05
Due: 02/28/06
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 04/30/05
Due: 04/30/06
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 12/31/04
Due: 12/31/05
Phase: N/A
Priority: Normal
Start: 01/31/01
End: 03/31/02
Due: 03/31/03